Edition:
India

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

6.45USD
18 Jan 2018
Change (% chg)

$-0.10 (-1.53%)
Prev Close
$6.55
Open
$6.50
Day's High
$6.55
Day's Low
$6.30
Volume
85,300
Avg. Vol
104,135
52-wk High
$6.75
52-wk Low
$2.25

Chart for

About

Vericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through... (more)

Overall

Beta: 3.12
Market Cap(Mil.): $160.84
Shares Outstanding(Mil.): 32.82
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics   

* VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​

02 Jan 2018

BRIEF-Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial

* VERICEL ENTERS INTO EXPANDED $25 MILLION DEBT FACILITIES WITH SILICON VALLEY BANK AND MIDCAP FINANCIAL TO SUPPORT ACCELERATING MACI UPTAKE AND INCREASED EPICEL USAGE

07 Dec 2017

BRIEF-Vericel reports Q3 loss per share $0.16

* Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

07 Nov 2017

BRIEF-‍Archon Capital Management reports a 7.56 pct passive stake in Vericel

* Archon Capital Management LLC reports a 7.56 pct passive stake in Vericel Corp of August 23 - SEC filing ​ Source text: (http://bit.ly/2vxJQCK) Further company coverage:

29 Aug 2017

BRIEF-Shanghai Pharmaceuticals Holding to bid for US firm Arbor

* Says it plans to bid for stake in U.S. specialty drug maker Arbor, clarifies media report

14 Aug 2017

BRIEF-Shanghai Fosun Pharmaceutical's unit to bid for US firm Arbor

Aug 14 Shanghai Fosun Pharmaceutical Group Co Ltd

14 Aug 2017

BRIEF-Vericel Q2 loss per share $0.07

* Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

09 Aug 2017

Earnings vs. Estimates